Skip to main content

Advertisement

Table 1 Table of ranges

From: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

Cancer N Acceptable ranges
Protein 1 Protein 2 Protein 3
MW
(kDa)
pI
(pH)
MW
(kDa)
pI
(pH)
MW
(kDa)
pI
(pH)
Bladder 25 63–66 4.2–5.6 42–48 4.1–4.8   
Blood cell (total) 88 34–47 3.5–4.5     
Breast 538 64–69 4.2–4.9     
Cervical 37 90–100 4.2–5.4     
Colorectal 90 80–96 4.4–5.4 50–65 4.2–5.3 33–46 3.8–5.2
Endometrial (uterine) 60 67–71 4.2–5.1 41–48 3.7–5.4   
Esophageal 9 42–47 4.6–5.2     
Gastric 10 120–188 4.7–5.5 50–62 4.5–5.6 45–53 2.4–3.6
Hepatocellular 19 58–70 4.5–5.0 34–40 4.1–5.2   
Kidney (renal cell) 21 69–73 4.7–5.4 54–61 4.1–5.2 38–43 3.7–4.3
 Leukemiaa 32 34–45 3.5–4.5     
Lung (total) 103 52–56 4.1–5.3     
 Lung, non-small cella 71 54–56 4.7–5.3     
 Lung, small-cella 32 52–53 4.1–4.6     
 Lymphomaa 33 43–45 3.5–4.5     
Melanoma 39 37–41 4.6–5.3     
Mesothelioma 25 60–68 3.8–4.1 38–44 3.8–4.6   
 Myelomaa 23 38–47 3.6–4.5     
Ovarian 102 72–90 3.7–5.0 37–47 3.7–5.0   
Pancreatic 62 48–51 3.9–5.4     
Prostate 182 71–88 5.1–6.5     
Sarcoma 22 50–55 5.2–5.6 37–45 4.3–4.9   
Squamous cell 46 57–68 5.0–5.4     
Testicular germ cell 5 61–62 5.0–5.4 42–45 4.4–4.7   
Thyroid follicular 14 48–56 4.7–5.1 37–42 4.5–5.2   
Thyroid papillary 22 56–67 4.5–5.0 37–44 3.2–3.6   
Totals 1519       
  1. aBracketed entries are aggregate cancers or subsets already represented in the totals as aggregates (lung) or subsets (blood cell cancers)